ERBB4 and schizophrenia: The key and novel finding of the study was that ErbB receptors were characterized by the opposite pattern of expression and activation: there was a lower expression of ErbB4 in schizophrenia relative to controls, but NRG1-induced activation of ErbB receptors led to an enhanced pro-inflammatory cytokine response.